Bioavailability Enhancement Technologies
A study conducted on terminated drug development projects revealed that majority of the drug candidates fail in early drug development phases, due to the problems associated with their pharmacokinetic profiles, ADME properties and toxicity-related issues.
For additional details, please visit
https://www.rootsanalysis.com/blog/bioavailability-enhancement-technologies/ or email sales@rootsanalysis.com
Share this page with your family and friends.